SCHEMBL2999874

SCHEMBL2999874

OB(O)c1ccc(-c2nc3ccc(-c4ccccc4)cc3s2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
LMNA P02545 2/20 0.57
NFKB1 P19838 2/20 0.57
NFKB2 Q00653 2/20 0.57
RELA Q04206 2/20 0.57
MAPT P10636 6/20 0.56
GAA P10253 5/20 0.56
ALDH1A1 P00352 5/20 0.56
GLA P06280 4/20 0.56
HPGD P15428 4/20 0.56
PKM P14618 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
PIK3CA P42336 1/20 0.54
PI4KA P42356 1/20 0.54
PI4KB Q9UBF8 1/20 0.54
APP P05067 7/20 0.52
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28524111 0.90 KDM4E (0.61) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL12408902 0.88 KDM4E (0.70) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL19733171 0.85 RAB9A (0.66) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL2380254 0.83 RAB9A (0.68) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL2995582 0.81 MAPT (0.67) KDM4ESMN1; SMN2LMNAMAPTGAA
SCHEMBL29939237 0.81 MAPT (0.79) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL27001616 0.81 MAPT (0.79) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL31319825 0.81 MAPT (0.79) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL30727497 0.81 APP (0.62) KDM4ESMN1; SMN2LMNANFKB1NFKB2
SCHEMBL13241670 0.79 KDM4E (0.59) KDM4ESMN1; SMN2LMNANFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190994-A1 THIAZOLE SYSTEM ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME LEE MI AE 2010-07-29 US disclosed
EP-2129738-A1 THIAZOLE SYSTEM ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME Gracel Display Inc. (KR) 2009-12-09 EP disclosed
WO-2008117976-A1 THIAZOLE SYSTEM ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME GRACEL DISPLAY INC. (KR) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190994-A1 THIAZOLE SYSTEM ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE USING THE SAME OCIAD1, OCIAD2, PPARD KDM4E 3995/4885SMN1; SMN2 4131/4885LMNA 3917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.